Ballicules.com

Mupirocin

BACTROBAN

What it isBacterial isoleucyl-tRNA synthetase inhibitor; impetigo and nasal staphylococcal decolonization.

Why this oneIts unusual target enables topical MRSA decolonization without systemic antibiotic exposure.

What limits itRepeated or prolonged courses select resistance; reserve it for short, defined topical regimens.

FDA-approved for

Off-label

FDA label

FDA dosingPopulationStartTargetMax
Topical bacterial skin infection (e.g., impetigo)adult & peds ≥2 monthsApply small amount TID for up to 10 days

Renal Avoid where absorption of large amounts of polyethylene glycol is possible in moderate/severe renal impairment

Hepatic Undefined

Instructions

Cautions

Adverse reactions

Pregnancy Insufficient human data; systemic absorption through intact skin is minimal

Lactation Unknown if present in milk; minimal systemic absorption — wash treated breast/nipple before feeding

NO BOXED WARNINGS

Principal riskLittle; topical

Cost, est. cash$10–$300/month

Generic entry2013

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk0 / 4

Legacy pregnancy categoryC

Defining liabilityLocal irritation or hypersensitivity; systemic toxicity is minimal with correct local use.

Mechanism of action: Mupirocin ballicule

Mupirocin ballicule: receptor binding, kinetics and half-life diagram

Open Mupirocin in the interactive console ↗

Memory aids: mascots and interaction avatars

Mupirocin BACTROBAN mascot mnemonic cartoon
“Moo person’s Bacteria band”
Mupirocin no kinetic interactions avatar
no kinetic interactions

Open Mupirocin in the interactive console ↗